The University of Chicago Header Logo

Search Results (12)

More Search Options
MatchTypeWhy
5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease.Academic Article Why?
A dynamic model of colonic concentrations of delayed-release 5-aminosalicylic acid (Asacol).Academic Article Why?
A dynamic model of once-daily 5-aminosalicylic acid predicts clinical efficacy.Academic Article Why?
Simulated comparison of topical and oral formulations of 5-aminosalicylate for the treatment of ulcerative colitis.Academic Article Why?
Long-term use of mesalamine (Rowasa) suppositories in remission maintenance of ulcerative proctitis.Academic Article Why?
Systematic review: the pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the management of ulcerative colitis.Academic Article Why?
Time to Symptom Resolution in Ulcerative Colitis With Multimatrix Mesalazine Treatment: A Pooled Analysis.Academic Article Why?
Ulcerative Colitis Remission Status After Induction With Mesalazine Predicts Maintenance Outcomes: the MOMENTUM Trial.Academic Article Why?
Aminosalicylic AcidConcept Why?
Hanauer, StephenPerson Why?
Long-term management of Crohn's disease with mesalamine capsules (Pentasa). Pentasa Crohn's Disease Compassionate Use Study Group.Academic Article Why?
Mesalamine delivery systems: do they really make much difference?Academic Article Why?
Mesalamine derivatives in the treatment of Crohn's disease.Academic Article Why?
The mesalamine wars heat up-enter balsalazide.Academic Article Why?
A pilot feasibility study of once daily versus conventional dosing mesalamine for maintenance of ulcerative colitis.Academic Article Why?
Per Page    Page  of 1
Next
Prev
Search Criteria
  • Mesalamine
Filter by Type
_
Click "Why?" to see why an item matched the search.